|
ST7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.671800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.712600E-01 |
| Normal-vs-Stage2 |
6.651400E-01 |
| Normal-vs-Stage3 |
2.842300E-03 |
| Normal-vs-Stage4 |
2.937600E-02 |
| Stage1-vs-Stage2 |
4.422800E-01 |
| Stage1-vs-Stage3 |
2.101600E-02 |
| Stage1-vs-Stage4 |
1.114580E-01 |
| Stage2-vs-Stage3 |
5.542000E-02 |
| Stage2-vs-Stage4 |
9.220400E-02 |
| Stage3-vs-Stage4 |
8.550400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.870500E-02 |
| Normal-vs-AfricanAmerican |
2.047000E-01 |
| Normal-vs-Asian |
5.138200E-02 |
| Caucasian-vs-AfricanAmerican |
6.179200E-01 |
| Caucasian-vs-Asian |
4.635600E-01 |
| AfricanAmerican-vs-Asian |
6.463200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.504490E-02 |
| Normal-vs-Female |
8.772600E-01 |
| Male-vs-Female |
4.695800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.697840E-01 |
| Normal-vs-Age(41-60Yrs) |
9.426100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.764610E-01 |
| Normal-vs-Age(81-100Yrs) |
6.382800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.722000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.868000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.677820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.434800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.648400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.261600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.744600E-01 |
| Normal-vs-Grade 2 |
2.799400E-01 |
| Normal-vs-Grade 3 |
2.786800E-01 |
| Normal-vs-Grade 4 |
5.68989999999436E-05 |
| Grade 1-vs-Grade 2 |
6.196600E-01 |
| Grade 1-vs-Grade 3 |
6.133000E-01 |
| Grade 1-vs-Grade 4 |
3.981600E-02 |
| Grade 2-vs-Grade 3 |
9.715800E-01 |
| Grade 2-vs-Grade 4 |
1.617290E-03 |
| Grade 3-vs-Grade 4 |
2.157200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.741900E-02 |
| Normal-vs-ccB subtype |
2.060600E-03 |
| ccA subtype-vs-ccB subtype |
1.24550000002444E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.183800E-01 |
| Normal-vs-N1 |
5.618100E-04 |
| N0-vs-N1 |
5.759800E-02 |
|
|
